Tag: ambulatory anesthesia

FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators

Editor's Note The US Food and Drug Administration (FDA) has designated Class 1 recalls—the most severe category indicating risk of serious injury or death—involving three systems: Atlan anesthesia workstations from Draeger, CADD-Solis ambulatory infusion pumps from Smiths Medical, and Trilogy Evo ventilators from Philips Respironics. FDA issued all three announcements…

Read More

By: Matt Danford
November 20, 2024
Share

Study: Digital tool detects preoperative pediatric anxiety, depression

Editor's Note A recent study presented at the American Society of Anesthesiologists’ 2024 meeting reveals that a computerized mental health assessment, KCAT, may effectively identify anxiety and depression in pediatric surgical patients. According to an October 20 report in Anesthesiology News, the single-center pilot study involved 65 children aged 7…

Read More

By: Matt Danford
November 18, 2024
Share

Study: Demand for anesthesiologists rises sharply, driven by job market, regional variations

Editor's Note A recent study by RIVANNA® Medical, a leader in medical imaging technology, highlights a rising interest in anesthesiologist careers across the US, showing a 46% increase in online job search activity from August 2020 to August 2024, Rivanna Medical reported in October 2024. The study analyzed search trends…

Read More

By: Tarsilla Moura
November 13, 2024
Share

GLP-1 labels carry pulmonary aspiration warning

Editor's Note The US Food and Drug Administration (FDA) has updated the labels of all treatments containing GLP-1 receptor agonists with a warning about warning about pulmonary aspiration during general anesthesia or deep sedation. Drugs and brand names listed in a November 8 report on the development from MedPage Today…

Read More

By: Matt Danford
November 12, 2024
Share

Research reveals racial disparity in postoperative pain management

Editor's Note Black patients are less likely to receive multimodal analgesia and more likely to be given additional oral opioids compared to white patients, according to research presented at the Anesthesiology 2024 annual meeting. According to an October 20 report on the retrospective study from the American Society of Anesthesiologists,…

Read More

By: Matt Danford
November 12, 2024
Share

Study: NSAIDs reduce risk of postoperative delirium

Editor's Note A study presented at the 2024 American Society of Anesthesiologists annual meeting suggests that non-salicylate NSAIDs may significantly reduce the risk of postoperative delirium, a serious complication affecting up to 15% of surgical patients, Anesthesiology News reported October 20. Delirium is especially prevalent in older adults and those…

Read More

By: Matt Danford
October 25, 2024
Share

Outpatient, ASC clinicians share perspectives on upcoming NOPAIN Act implementation

Editor's Note On October 14, Anesthesiology News published a monograph featuring clinical perspectives on how “those working in the trenches of postsurgical pain management” are preparing for the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act, which outlines new, separate Medicare reimbursement for certain non-opioid analgesics in outpatient and ambulatory…

Read More

By: Matt Danford
October 16, 2024
Share

Anesthesia staffing, communication, patient safety: Q&A with OR Manager Conference speakers

Editor's Note Capacity issues persist within the anesthesia workforce, leaving perioperative leaders tasked with maintaining efficient operations and safe practices for patients through surgery. We spoke with leaders from SCA Health, Stormont Vail Health, and Heartland Anesthesia & Consulting to find out other challenges anesthesia providers are facing, and how…

Read More

By: Lindsay Botts
September 17, 2024
Share

Anesthesia workforce challenges taking center stage

Every year, OR Manager shines a light on staffing issues via the Salary/Career Survey. In this issue, two articles take a careful look at the career and profile of the perioperative leader in both inpatient and outpatient settings. Next month, two more articles will do the same with salary trends…

Read More

By: Tarsilla Moura
August 28, 2024
Share

FDA approves single-dose propofol amid drug shortage

Editor's Note The Food and Drug Administration (FDA) approved Amneal Pharmaceuticals' Abbreviated New Drug Application for single-dose vials of propofol injectable emulsion, Anesthesiology News August 23 reports. The newly approved formulations include 200 mg/20 mL, 500 mg/50 mL, and 1,000 mg/100 mL vials. Propofol is widely used for anesthesia and…

Read More

By: Tarsilla Moura
August 28, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat